North America Cardiac Marker Testing Market Size, Share, Trends 2021
©
North America Cardiac Marker Testing Market is anticipated to grow at 7.89% CAGR from 2016 to 2021 and it is estimated that the North-America market was valued at USD 0.88 billion in 2016 and is expected to reach USD 1.28 billion by 2021.Cardiac markers are substances released into the blood when the heart is stressed or damaged. These markers include hormones, enzymes, and proteins. Measuring these biomarkers help to diagnose various heart syndromes such as acute coronary syndrome, cardiac ischemia, and conditions associated with obstructed blood flow to the heart. Generally, multiple cardiac marker tests are done by physicians over several hours to keep track of the blood level rise and to understand the severity of a heart attack.
Full report at: http://www.marketdataforecast.com/market-reports/north-america-cardiac-marker-testing-market-4984/
Factor such as rise in the prevalence and instances of cardiovascular diseases is among the key driving factors for the growth of this market. Moreover, a number of factors such as growth in the instances of cardiovascular diseases, the rapid increase in the geriatric population, growth in the funding from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the cardiac marker testing market. However, technical problems related to sample collection and storage and issues related to regulatory and reimburse schemes are some of the having a negative impact on the growth of the market.
North America Cardiac Marker Testing market segmentation by Type, Product, Disease, and Testing. On the basis of Type, it is segmented into Troponin I & T, CK-MB, Myoglobin, BNP, and hsCRP. The creatine kinase segment is further segmented into M & B subunits: CK-MM, CK-MB, and CK-BB. The troponin cardiac biomarkers segment held the largest share of this market segment. On the basis of Product, it is segmented into Reagent and Instrument. The instrument segment is furtherer segmented into Chemiluminescence, Immunofluorescence, Immunochromatography, and ELISA. On the basis of Disease, it is segmented into Acute Coronary Syndrome, Myocardial Infarction, and Congestive Heart Failure. ACS is expected to be the fasting growing segment driven. Myocardial infarction is anticipated to be the second fastest growing segment. On the basis of Testing, it is segmented into Lab and POC. The laboratory testing segment is expected to hold the largest share of this market segment, while the point-of-care testing segment is expected to register the highest growth rate in this market segment.
Request sample: http://www.marketdataforecast.com/market-reports/north-america-cardiac-marker-testing-market-4984/request-sample
On the basis of geography, the market is analyzed under various regions namely U.S. and Canada. North America held the largest share of the global cardiac marker testing market. Factors such as public–private initiatives to increase awareness related to early cardiac disease diagnosis in patients and physicians and increasing knowledge about technological advancements among lab professionals and cardiologists due to ongoing conferences and seminars are the key factors aiding the growth of the markets.
North America Cardiac Marker Testing market leaders are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS Roche Diagnostics Ltd., Abbott Laboratories, Siemens AG, Danaher Corporation, Alere Inc., bioMérieux SA, LSI Medience Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd, and Guangzhou Wondfo Biotech Co. Ltd.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Full report at: http://www.marketdataforecast.com/market-reports/north-america-cardiac-marker-testing-market-4984/
Factor such as rise in the prevalence and instances of cardiovascular diseases is among the key driving factors for the growth of this market. Moreover, a number of factors such as growth in the instances of cardiovascular diseases, the rapid increase in the geriatric population, growth in the funding from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the cardiac marker testing market. However, technical problems related to sample collection and storage and issues related to regulatory and reimburse schemes are some of the having a negative impact on the growth of the market.
North America Cardiac Marker Testing market segmentation by Type, Product, Disease, and Testing. On the basis of Type, it is segmented into Troponin I & T, CK-MB, Myoglobin, BNP, and hsCRP. The creatine kinase segment is further segmented into M & B subunits: CK-MM, CK-MB, and CK-BB. The troponin cardiac biomarkers segment held the largest share of this market segment. On the basis of Product, it is segmented into Reagent and Instrument. The instrument segment is furtherer segmented into Chemiluminescence, Immunofluorescence, Immunochromatography, and ELISA. On the basis of Disease, it is segmented into Acute Coronary Syndrome, Myocardial Infarction, and Congestive Heart Failure. ACS is expected to be the fasting growing segment driven. Myocardial infarction is anticipated to be the second fastest growing segment. On the basis of Testing, it is segmented into Lab and POC. The laboratory testing segment is expected to hold the largest share of this market segment, while the point-of-care testing segment is expected to register the highest growth rate in this market segment.
Request sample: http://www.marketdataforecast.com/market-reports/north-america-cardiac-marker-testing-market-4984/request-sample
On the basis of geography, the market is analyzed under various regions namely U.S. and Canada. North America held the largest share of the global cardiac marker testing market. Factors such as public–private initiatives to increase awareness related to early cardiac disease diagnosis in patients and physicians and increasing knowledge about technological advancements among lab professionals and cardiologists due to ongoing conferences and seminars are the key factors aiding the growth of the markets.
North America Cardiac Marker Testing market leaders are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS Roche Diagnostics Ltd., Abbott Laboratories, Siemens AG, Danaher Corporation, Alere Inc., bioMérieux SA, LSI Medience Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd, and Guangzhou Wondfo Biotech Co. Ltd.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases